MyFinsight
Home
Blog
About
Contact
Download
Download image
Other Products
$67,131K
(34.13%↑ Y/Y)
Baqsimi
$32,434K
(-15.44%↓ Y/Y)
Primatenemist
$29,763K
(2.45%↑ Y/Y)
Epinephrine
$19,213K
(3.37%↑ Y/Y)
Lidocaine
$13,460K
(-1.35%↓ Y/Y)
Glucagon
$9,170K
(-56.00%↓ Y/Y)
Revenues
$171,171K
(0.38%↑ Y/Y)
Gross profit
$70,322K
(-17.51%↓ Y/Y)
Cost of revenues
$100,849K
(18.26%↑ Y/Y)
Income from operations
$13,630K
(-63.45%↓ Y/Y)
Total operating
expenses
$56,692K
(18.21%↑ Y/Y)
Income before income
taxes
$10,052K
(-67.43%↓ Y/Y)
Total non-operating
income (expenses), net
-$3,578K
(44.36%↑ Y/Y)
Interest income
$2,400K
(14.89%↑ Y/Y)
Other income
(expenses), net
$575K
(125.74%↑ Y/Y)
Research and development
$26,737K
(33.05%↑ Y/Y)
General and
administrative
$18,028K
(12.70%↑ Y/Y)
Selling, distribution,
and marketing
$11,927K
(0.51%↑ Y/Y)
Net income
$6,420K
(-74.61%↓ Y/Y)
Income tax provision
$3,632K
(-34.88%↓ Y/Y)
Interest expense
$6,553K
(4.25%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)